These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 36460448)

  • 1. Macro-level drivers of SARS-CoV-2 transmission: A data-driven analysis of factors contributing to epidemic growth during the first wave of outbreaks in the United States.
    Watts MJ
    Spat Spatiotemporal Epidemiol; 2022 Nov; 43():100539. PubMed ID: 36460448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study.
    Post LA; Issa TZ; Boctor MJ; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Faber JMM; Culler K; Brandt CA; Oehmke JF
    J Med Internet Res; 2020 Dec; 22(12):e24286. PubMed ID: 33216726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of social distancing on early SARS-CoV-2 transmission in the United States.
    Sanchez JN; Reyes GA; Martínez-López B; Johnson CK
    Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy Interventions, Social Distancing, and SARS-CoV-2 Transmission in the United States: A Retrospective State-level Analysis.
    Dreher N; Spiera Z; McAuley FM; Kuohn L; Durbin JR; Marayati NF; Ali M; Li AY; Hannah TC; Gometz A; Kostman JT; Choudhri TF
    Am J Med Sci; 2021 May; 361(5):575-584. PubMed ID: 33775425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of an early SARS-CoV-2 epidemic in the United States.
    Zeller M; Gangavarapu K; Anderson C; Smither AR; Vanchiere JA; Rose R; Snyder DJ; Dudas G; Watts A; Matteson NL; Robles-Sikisaka R; Marshall M; Feehan AK; Sabino-Santos G; Bell-Kareem AR; Hughes LD; Alkuzweny M; Snarski P; Garcia-Diaz J; Scott RS; Melnik LI; Klitting R; McGraw M; Belda-Ferre P; DeHoff P; Sathe S; Marotz C; Grubaugh ND; Nolan DJ; Drouin AC; Genemaras KJ; Chao K; Topol S; Spencer E; Nicholson L; Aigner S; Yeo GW; Farnaes L; Hobbs CA; Laurent LC; Knight R; Hodcroft EB; Khan K; Fusco DN; Cooper VS; Lemey P; Gardner L; Lamers SL; Kamil JP; Garry RF; Suchard MA; Andersen KG
    Cell; 2021 Sep; 184(19):4939-4952.e15. PubMed ID: 34508652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative effects of non-pharmaceutical interventions on wave one Covid-19 mortality: natural experiment in 130 countries.
    Stokes J; Turner AJ; Anselmi L; Morciano M; Hone T
    BMC Public Health; 2022 Jun; 22(1):1113. PubMed ID: 35659646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Pozo-Martin F; Weishaar H; Cristea F; Hanefeld J; Bahr T; Schaade L; El Bcheraoui C
    Eur J Epidemiol; 2021 Jun; 36(6):629-640. PubMed ID: 34114189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.
    Bisanzio D; Reithinger R; Alqunaibet A; Almudarra S; Alsukait RF; Dong D; Zhang Y; El-Saharty S; Herbst CH
    BMC Med; 2022 Feb; 20(1):51. PubMed ID: 35125108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of social and demographic factors on the spread of the SARS-CoV-2 epidemic in the town of Nice.
    Mariné Barjoan E; Chaarana A; Festraëts J; Géloen C; Prouvost-Keller B; Legueult K; Pradier C
    BMC Public Health; 2023 Jun; 23(1):1098. PubMed ID: 37280635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave.
    Davis JT; Chinazzi M; Perra N; Mu K; Pastore Y Piontti A; Ajelli M; Dean NE; Gioannini C; Litvinova M; Merler S; Rossi L; Sun K; Xiong X; Longini IM; Halloran ME; Viboud C; Vespignani A
    Nature; 2021 Dec; 600(7887):127-132. PubMed ID: 34695837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in the Effectiveness of Non-pharmaceutical Interventions During the First SARS-CoV2 Wave in the United States.
    Pan WK; Fernández D; Tyrovolas S; Iago GV; Dasgupta RR; Zaitchik BF; Lantos PM; Woods CW
    Front Public Health; 2021; 9():754696. PubMed ID: 34912768
    [No Abstract]   [Full Text] [Related]  

  • 14. Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.
    Pana TA; Bhattacharya S; Gamble DT; Pasdar Z; Szlachetka WA; Perdomo-Lampignano JA; Ewers KD; McLernon DJ; Myint PK
    BMJ Open; 2021 Feb; 11(2):e042034. PubMed ID: 33536319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study.
    Rader B; White LF; Burns MR; Chen J; Brilliant J; Cohen J; Shaman J; Brilliant L; Kraemer MUG; Hawkins JB; Scarpino SV; Astley CM; Brownstein JS
    Lancet Digit Health; 2021 Mar; 3(3):e148-e157. PubMed ID: 33483277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilation Improvement Strategies Among K-12 Public Schools - The National School COVID-19 Prevention Study, United States, February 14-March 27, 2022.
    Pampati S; Rasberry CN; McConnell L; Timpe Z; Lee S; Spencer P; Moore S; Mead KR; Murray CC; Deng X; Iachan R; Tripathi T; Martin SB; Barrios LC
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(23):770-775. PubMed ID: 35679198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
    Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
    Preskorn SH
    J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021.
    Nguyen MH; Nguyen THT; Molenberghs G; Abrams S; Hens N; Faes C
    BMC Infect Dis; 2023 Jun; 23(1):428. PubMed ID: 37355572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic Landscape and Forecasting of SARS-CoV-2 in India.
    Rajendrakumar AL; Nair ATN; Nangia C; Chourasia PK; Chourasia MK; Syed MG; Nair AS; Nair AB; Koya MSF
    J Epidemiol Glob Health; 2021 Mar; 11(1):55-59. PubMed ID: 32959618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.